Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Opelousas › NPI 1447230388
Hospital

Opelousas General Hospital Authority

Opelousas General Hospital Authority was paid $27.17M by Medicaid between Jan 2018 and Dec 2024, across 261 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.

33Billing provider infoOPELOUSAS GENERAL HOSPITAL AUTHORITY
OPELOUSAS, LA 70570
33aNPI1447230388assigned 01/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.17M
24GClaims988,453
24DCodes billed261
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#16 of 96
Median peer was paid$5.17M
This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018145,216$3.24M
2019160,632$3.68M
2020119,355$2.62M
2021161,607$4.18M
2022172,541$5.20M
2023146,087$5.08M
2024incomplete83,015$3.17M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 24% 86,945 77,136 $6.59M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 48,749 42,292 $5.38M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 18,896 16,129 $2.76M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3.8% 10,994 9,700 $1.04M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2.9% 26,427 6,500 $777K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.7% 20,582 15,990 $726K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.5% 13,780 12,362 $688K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.5% 34,488 27,656 $678K
96375 Therapeutic injection; each additional sequential IV push 2.4% 14,836 10,426 $655K
80053 Comprehensive metabolic panel 1.9% 78,480 63,595 $511K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 13,613 10,277 $483K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 93,409 74,762 $443K
249 more codes
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.5% 3,191 $405K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.4% 5,371 $393K
96361 Intravenous infusion, hydration; each additional hour 1.4% 14,338 $390K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 1,344 $374K
70450 Computed tomography, head or brain; without contrast material 1.3% 2,681 $357K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.2% 10,658 $331K
71045 Radiologic examination, chest; single view 1.1% 15,603 $304K
71046 Radiologic examination, chest; 2 views <1% 10,061 $261K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,843 $259K
36415 Collection of venous blood by venipuncture <1% 97,446 $180K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,641 $144K
95811 <1% 288 $133K
87631 <1% 4,940 $121K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 6,907 $117K
99214 Doctor's office visit, returning patient (more involved) <1% 2,956 $111K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 1,111 $110K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,124 $102K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,543 $102K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 220 $80K
84443 Thyroid stimulating hormone (TSH) <1% 7,517 $79K
87653 <1% 2,502 $75K
86738 <1% 6,814 $73K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 735 $71K
81025 <1% 10,769 $67K
76830 Ultrasound, transvaginal <1% 552 $66K
99213 Doctor's office visit, returning patient (routine) <1% 3,021 $65K
84484 <1% 9,756 $64K
81001 <1% 35,867 $62K
80061 Lipid panel <1% 6,626 $58K
99215 Doctor's office visit, returning patient (complex) <1% 1,208 $57K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,733 $53K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,363 $48K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,179 $41K
95813 <1% 235 $40K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 996 $39K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,381 $36K
C1769 Guide wire <1% 1,878 $33K
80048 Basic metabolic panel (calcium, ionized) <1% 6,541 $32K
86803 <1% 2,712 $31K
87088 <1% 5,006 $30K
74019 <1% 916 $28K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 88 $28K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 945 $27K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 577 $26K
G0378 Hospital observation service, per hour <1% 822 $24K
83690 <1% 5,426 $24K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,215 $22K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,500 $21K
83880 <1% 1,083 $20K
83036 Hemoglobin; glycosylated (A1C) <1% 3,171 $20K
86780 <1% 1,838 $20K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 136 $19K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 735 $19K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 730 $19K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,707 $18K
87449 <1% 1,444 $16K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,048 $16K
80055 <1% 830 $16K
83735 <1% 4,145 $16K
86900 <1% 2,193 $15K
81003 <1% 12,883 $15K
84436 <1% 4,182 $15K
37252 <1% 27 $14K
86762 <1% 1,381 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 465 $14K
84479 <1% 4,186 $14K
86850 <1% 3,007 $14K
86703 <1% 1,364 $13K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 38 $13K
87340 <1% 1,712 $13K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,500 $12K
76770 <1% 322 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,967 $11K
77067 Screening mammography, bilateral, including computer-aided detection <1% 407 $11K
83970 <1% 326 $11K
87481 <1% 266 $11K
86140 <1% 2,797 $10K
84702 <1% 898 $10K
86901 <1% 2,207 $10K
87081 <1% 1,661 $10K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 132 $10K
95886 <1% 89 $9K
0223U <1% 47 $9K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 43 $9K
C1753 Catheter, intravascular ultrasound <1% 72 $9K
J2469 Injection, palonosetron hcl, 25 mcg <1% 190 $9K
81513 <1% 95 $9K
82550 <1% 2,242 $9K
93975 <1% 130 $9K
85651 <1% 2,915 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,197 $8K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 502 $8K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 296 $7K
76775 <1% 219 $7K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 43 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 92 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 1,073 $7K
82042 <1% 1,445 $6K
82150 <1% 1,536 $6K
82728 <1% 575 $6K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 14 $6K
86160 <1% 690 $6K
83021 <1% 419 $6K
96417 <1% 187 $6K
82553 <1% 878 $5K
82570 <1% 1,458 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,208 $5K
96376 <1% 167 $5K
80074 <1% 169 $5K
75822 <1% 47 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 974 $5K
82947 <1% 1,785 $5K
72100 <1% 224 $5K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 42 $4K
96415 <1% 154 $4K
85379 <1% 692 $4K
82950 <1% 1,353 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 53 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 26 $4K
86592 <1% 1,189 $4K
82607 <1% 427 $4K
71250 <1% 33 $4K
84439 <1% 561 $4K
87400 <1% 628 $4K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 100 $3K
84100 <1% 1,128 $3K
85730 <1% 1,254 $3K
87040 <1% 632 $3K
72141 <1% 13 $3K
J3230 Injection, chlorpromazine hcl, up to 50 mg <1% 232 $3K
84550 <1% 1,059 $3K
82746 <1% 286 $3K
85610 <1% 1,618 $3K
70551 Magnetic resonance imaging, brain; without contrast material <1% 14 $3K
94726 <1% 105 $3K
82677 <1% 120 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,988 $2K
86787 <1% 310 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 14 $2K
73560 <1% 96 $2K
37253 <1% 25 $2K
80320 <1% 1,930 $2K
82105 <1% 166 $2K
77336 <1% 66 $2K
82164 <1% 238 $2K
82043 <1% 492 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,491 $2K
86038 <1% 224 $2K
87070 <1% 219 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 151 $2K
36012 <1% 15 $2K
94729 <1% 95 $2K
86021 <1% 346 $2K
86336 <1% 120 $2K
82962 <1% 602 $2K
85660 <1% 388 $2K
85018 <1% 1,479 $1K
86480 <1% 28 $1K
85014 <1% 1,486 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,142 $1K
83550 <1% 205 $1K
76801 <1% 13 $1K
82945 <1% 234 $1K
87186 <1% 191 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,620 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 81 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 69 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,131 $1K
85027 <1% 195 $1K
94761 <1% 311 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,840 $1K
72040 <1% 30 $1K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 146 $1K
83540 <1% 199 $963.68
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,559 $894.77
94010 <1% 30 $818.37
73630 <1% 30 $813.78
86431 <1% 198 $728.91
74018 <1% 27 $722.15
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 400 $706.36
82951 <1% 94 $695.61
83655 <1% 56 $691.98
J2060 Injection, lorazepam, 2 mg <1% 516 $644.34
83605 <1% 110 $613.21
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 524 $601.55
86334 <1% 34 $590.48
J1030 Injection, methylprednisolone acetate, 40 mg <1% 75 $588.87
84166 <1% 34 $526.97
J1644 Injection, heparin sodium, per 1000 units <1% 448 $469.47
83615 <1% 84 $428.84
J2270 Injection, morphine sulfate, up to 10 mg <1% 310 $410.17
73030 <1% 21 $344.63
72084 <1% 13 $342.48
84144 <1% 16 $333.76
80069 <1% 45 $303.80
86147 <1% 24 $297.15
80051 <1% 84 $285.09
82803 <1% 73 $279.49
86308 <1% 55 $264.50
84403 <1% 15 $258.10
85045 <1% 66 $255.36
J2704 Injection, propofol, 10 mg <1% 3,968 $253.93
86141 <1% 32 $233.10
J3490 Unclassified drugs <1% 204 $232.67
84140 <1% 12 $227.37
82627 <1% 15 $222.30
J0780 Injection, prochlorperazine, up to 10 mg <1% 14 $198.96
J7510 Prednisolone oral, per 5 mg <1% 73 $195.11
82952 <1% 60 $188.16
83001 <1% 15 $185.80
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 184 $181.86
86255 <1% 32 $180.75
83002 <1% 15 $166.68
96523 <1% 165 $162.38
J1040 Injection, methylprednisolone acetate, 80 mg <1% 16 $129.20
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 111 $120.45
J7120 Ringers lactate infusion, up to 1000 cc <1% 69 $119.71
84703 <1% 20 $108.68
86704 <1% 15 $108.45
86705 <1% 15 $105.93
83525 <1% 18 $102.87
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 447 $91.41
87077 <1% 17 $89.70
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 172 $87.77
85613 <1% 13 $76.64
C9113 Injection, pantoprazole sodium, per vial <1% 44 $68.54
84270 <1% 15 $62.40
85041 <1% 563 $56.21
87205 <1% 17 $34.16
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 42 $28.65
84155 <1% 73 $22.42
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 25 $15.01
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 45 $6.70
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 37 $0.80
90791 Psychiatric diagnostic evaluation 0% 294 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 8,584 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 0% 4,180 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 109 $0.00
90832 Psychotherapy session, about 30 minutes 0% 796 $0.00
36005 0% 34 $0.00
02414 0% 27 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 108 $0.00
C1780 Lens, intraocular (new technology) 0% 109 $0.00
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes 0% 16,049 $0.00
00000 0% 1,890 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 18 $0.00
80329 0% 471 $0.00
L8699 Prosthetic implant, not otherwise specified 0% 14 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSOILEAU, MICHELLE (CFO)
Same official

Other billing entities under SOILEAU, MICHELLE

Full network →
ProviderLocationPaid
Opelousas General Hospital AuthorityOpelousas, LA$1.18M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.